Peanut allergy immunotherapy - DBV Technologies

Drug Profile

Peanut allergy immunotherapy - DBV Technologies

Alternative Names: DBV 712; EPIT® Peanut; Viaskin Peanut

Latest Information Update: 26 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator DBV Technologies
  • Class Allergens; Antiallergics; Food allergy immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Peanut hypersensitivity

Most Recent Events

  • 02 Mar 2018 Adverse events and efficacy data from a phase III trial in Peanut hypersensitivity presented at the Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI-2018)
  • 14 Feb 2018 DBV Technologies announces intention to submit BLA to the US FDA for Peanut hypersensitivity (In children) in 2H 2018
  • 22 Sep 2017 DBV Technologies completes the phase III PEPITES trial for Peanut hypersensitivity (In Children) in USA, Canada, Australia, Ireland and Germany (NCT02636699)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top